Dapsone
Dapsone is an antibiotic-type medicine used to treat leprosy and dermatitis herpetiformis in tablet form, and acne vulgaris as a topical gel.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 19 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Dapsone: Patient Information Guide
A plain-language walkthrough of Dapsone — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Dapsone is used for several different conditions depending on the form and product used.
- Dermatitis herpetiformis — Dapsone tablets treat this chronic, itchy blistering skin condition; a gluten-free diet may help reduce the amount of dapsone needed over time
- Leprosy — Dapsone tablets treat all forms of leprosy where the bacteria have not developed resistance to dapsone; it must be used in combination with other anti-leprosy medicines to prevent resistance
- Acne vulgaris — Aczone Gel, 7.5% and dapsone gel are applied to the skin to treat acne in patients 9 years and older; this topical form is not used for leprosy or dermatitis herpetiformis
⚙️How it works▾
For leprosy, dapsone works both by killing Mycobacterium leprae (the bacteria that causes leprosy) and by slowing its growth. This dual action — bactericidal and bacteriostatic — helps bring the infection under control. How dapsone works in dermatitis herpetiformis has not been established. The mechanism of action of dapsone gel in treating acne is also not known.
💊How it's taken▾
Dapsone tablets are taken by mouth once daily. Your prescriber will tailor the dose to your condition and response, so always follow their guidance — do not adjust the dose on your own. For leprosy, treatment must not be interrupted and is always combined with other anti-leprosy medicines. For dermatitis herpetiformis, the dose is adjusted down to the lowest effective level, and a strict gluten-free diet may allow some people to reduce or eventually eliminate the need for the tablet over months to years.
Aczone Gel, 7.5% and dapsone gel are applied to the skin — for topical use only. Aczone Gel, 7.5% is applied once daily; dapsone gel, 5% is applied twice daily. Wash and dry skin gently before applying, use about a pea-sized amount, and rub in completely. If there's no improvement after 12 weeks, your prescriber should reassess the treatment.
🤒Side effects — in detail▾
The most common side effects depend on how dapsone is used.
- Topical gel: oiliness or peeling, dryness, and redness at the site of application
- Topical gel: temporary yellow or orange skin or hair discoloration if benzoyl peroxide is used at the same time
- Topical gel (postmarketing reports): rash, facial swelling, or lip/eye swelling
- Oral dapsone: nausea, abdominal pain, headache
- Oral dapsone (serious): hemolytic anemia, agranulocytosis (dangerous drop in white blood cells), peripheral neuropathy (nerve damage with muscle weakness)
- Oral dapsone (serious): severe skin reactions including toxic epidermal necrolysis and blistering
Serious blood problems and severe skin reactions require prompt medical attention. Stop taking dapsone and contact your doctor immediately if you notice any of these signs.
⚠️Warnings & precautions▾
The most critical risk with oral dapsone is serious blood toxicity — including a life-threatening drop in white blood cells (agranulocytosis), aplastic anemia, and hemolytic anemia. Deaths have been reported. Regular blood count monitoring is required, especially in the early months of treatment. Tell your doctor right away if you develop a sore throat, fever, unusual paleness, purple skin spots, or yellowing of the skin or eyes.
- Methemoglobinemia (low blood oxygen from changes in red blood cells): both oral and topical dapsone can cause this. Signs include bluish or slate-grey coloring of lips, nails, or mouth lining. People with G6PD deficiency or congenital methemoglobinemia are at higher risk. Seek immediate medical care if this occurs.
- Hemolysis (breakdown of red blood cells): higher risk in people with G6PD deficiency, which is more common in those of African, South Asian, Middle Eastern, or Mediterranean ancestry. Avoid topical dapsone gel in patients also taking oral dapsone or antimalarial drugs.
- Severe skin reactions: oral dapsone has been associated with toxic epidermal necrolysis and severe blistering — stop the medicine and seek care immediately if a serious skin reaction develops.
- Peripheral neuropathy (nerve damage causing muscle weakness): reported with oral dapsone; no cases were seen in topical dapsone clinical trials.
🔀What it interacts with▾
Dapsone can interact with several medicines — let your prescriber and pharmacist know everything you take.
- Trimethoprim-sulfamethoxazole (TMP/SMX) — raises dapsone and its metabolite levels in the blood; increases hemolysis risk in people with G6PD deficiency when used with topical dapsone
- Topical benzoyl peroxide — applying after dapsone gel may cause temporary yellow or orange discoloration of skin and facial hair
- Rifampin, anticonvulsants (anti-seizure medicines), St. John's wort — may increase formation of a dapsone byproduct linked to hemolysis; relevant with oral dapsone
- Pyrimethamine and other folic acid antagonists — increase the risk of blood cell problems with oral dapsone
- Drugs that cause methemoglobinemia (e.g., benzocaine, chloroquine, nitrates, nitroglycerin, phenytoin, primaquine, sulfonamides) — combined use with dapsone raises the risk of methemoglobinemia
- Oral dapsone or antimalarial medicines — should not be used at the same time as topical dapsone gel due to increased hemolysis risk
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Allergy to dapsone: do not use if you are allergic to dapsone or its derivatives — this is a contraindication
- G6PD deficiency: tell your doctor; you are at higher risk of hemolysis. This enzyme deficiency is more common in people of African, South Asian, Middle Eastern, or Mediterranean descent
- Congenital or idiopathic methemoglobinemia: topical dapsone gel should be avoided if you have this condition
- Pregnancy: no adequate human data exist for topical dapsone in pregnancy; animal studies at high oral doses showed harm. Discuss risks and benefits with your doctor
- Breastfeeding: oral dapsone appears in breast milk and may cause hemolytic anemia in nursing infants, especially those with G6PD deficiency. Topical absorption is much lower, but discuss with your doctor
- Children: Aczone Gel, 7.5% and dapsone gel are approved for acne in patients 9 and older. Safety and efficacy of dapsone gel, 5% was evaluated in children aged 12–17
- Older adults: limited clinical trial data exist for topical dapsone in those 65 and over; use with care and discuss with your prescriber
- Severe heart or lung disease: hemolysis and methemoglobin effects may be harder for these patients to tolerate; close monitoring is needed with oral dapsone
🚑If you take too much▾
Taking too much dapsone by mouth can cause nausea, vomiting, and unusual excitability within minutes to up to 24 hours. Severe cases may involve methemoglobinemia (causing dangerous low blood oxygen), convulsions, or severe blue-grey skin color — these require emergency treatment. If you suspect an overdose, seek emergency medical help immediately.
🔬Pharmacokinetics — how your body processes it▾
When dapsone gel, 7.5% is applied to the skin once daily, steady-state blood levels are reached within about 7 days. The amount of dapsone that enters the bloodstream from the topical gel is expected to be roughly 1% of what would be absorbed from an oral dose — meaning the systemic exposure is very low. Studies showed that age (12–15 vs. 16 and older), gender, and race did not meaningfully affect how the body handled topical dapsone, and exposure did not build up over a year of use.
📦How to store it▾
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) . Protect from light.
📄 Written from Dapsone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Dapsone
215 supplements and herbal products have documented interactions with Dapsone in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 7
- Moderate · 167
- Minor · 41
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Dapsone has been associated with lower levels of 7 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 6
- Moderate · 1
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Dapsone — the kind of thing our pharmacy team would talk through with you at the counter.
What is dapsone actually used for? ▾
How do I use Aczone Gel correctly? ▾
What side effects should I watch out for? ▾
I have a G6PD deficiency — is dapsone safe for me? ▾
Are there medicines or products I need to avoid while using dapsone? ▾
Can I use dapsone if I'm pregnant or breastfeeding? ▾
Is Dapsone available over the counter? ▾
When was Dapsone first available? ▾
Who makes Dapsone? ▾
💬 Answers drafted from Dapsone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Dapsone comes
Dapsone is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Dapsone tablets treat dermatitis herpetiformis (a chronic blistering, itchy skin condition)
- Dapsone tablets treat leprosy — all forms except those with proven dapsone resistance
- Dapsone tablets are taken by mouth once daily; your prescriber will set and adjust your dose based on your response
- For leprosy, Dapsone tablets must be taken continuously without interruption, in combination with other anti-leprosy medicines as directed
- For dermatitis herpetiformis, dosage is adjusted individually — a gluten-free diet may reduce the amount needed over time
- Do not stop or change your dose without talking to your prescriber first
Topical cream, ointment or gel
How this form is used
- Aczone Gel, 7.5% is used for the topical treatment of acne vulgaris in patients 9 years of age and older
- Dapsone gel is used for the topical treatment of acne vulgaris in patients 9 years of age and older
- Aczone Gel, 7.5%: gently wash and pat dry the skin, then apply a pea-sized amount in a thin layer to the entire face once daily; a thin layer may also be applied to other affected areas
- Aczone Gel, 7.5%: rub in gently and completely; for topical use only — do not use on eyes, by mouth, or vaginally
- Dapsone gel, 5%: apply a pea-sized amount in a thin layer to acne-affected areas twice daily; wash hands after application
- If there is no improvement after 12 weeks, check with your prescriber about whether to continue treatment
📊 Dapsone across the U.S. market
How Dapsone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (18) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Dapsone is used
A general measure of how commonly Dapsone is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Dapsone is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Dapsone prescribed? Of the 1,596 medications we measure, Dapsone ranks #663 by Medicaid prescriptions — more than 58% of them.
Utilization by Dapsone product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
dapsone 0.05 MG/MG Topical Gel Most dispensed
Summed across the 14 of 26 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 607295
dapsone 100 MG Oral Tablet
Summed across the 6 of 41 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197557
dapsone 0.075 MG/MG Topical Gel
Summed across the 15 of 36 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1741905
dapsone 25 MG Oral Tablet
Summed across the 5 of 43 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197558
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Dapsone, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 40 of 146 listed Dapsone NDCs with Medicaid activity.
🔍 Compare Dapsone products
A representative set of FDA-listed product records for Dapsone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 25 mg | Oral | ANI Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | ANI Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC | ANDA | View NDC → |
| 100 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC | ANDA | View NDC → |
| 25 mg | Oral | AvKARE × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | ANDA | View NDC → |
| 25 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 100 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 100 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 25 mg | Oral | Everest Life Sciences. LLC | ANDA | View NDC → |
| 100 mg | Oral | Everest Life Sciences. LLC | ANDA | View NDC → |
| 25 mg | Oral | Golden State Medical Supply, Inc. × 3 listings | ANDA | View NDC → |
| 100 mg | Oral | Golden State Medical Supply, Inc. × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Jacobus Pharmaceutical Company, Inc. × 3 listings | ANDA | View NDC → |
| 100 mg | Oral | Jacobus Pharmaceutical Company, Inc. × 3 listings | ANDA | View NDC → |
| 25 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| 100 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| 25 mg | Oral | Nostrum Laboratories, Inc. × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | Nostrum Laboratories, Inc. × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Novitium Pharma LLC | ANDA | View NDC → |
| 100 mg | Oral | Novitium Pharma LLC | ANDA | View NDC → |
| 25 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 100 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 25 mg | Oral | Rising Pharma Holdings, Inc. × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | Rising Pharma Holdings, Inc. × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Seton Pharmaceuticals | ANDA | View NDC → |
| 100 mg | Oral | Seton Pharmaceuticals | ANDA | View NDC → |
| 25 mg | Oral | Solis Pharmaceuticals Inc. | ANDA | View NDC → |
| 100 mg | Oral | Solis Pharmaceuticals Inc. | ANDA | View NDC → |
| 25 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 100 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 25 mg | Oral | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 100 mg | Oral | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 25 mg | Oral | Viona Pharmaceuticals Inc | ANDA | View NDC → |
| 100 mg | Oral | Viona Pharmaceuticals Inc | ANDA | View NDC → |
| 25 mg | Oral | Westminster Pharmaceuticals, LLC × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | Westminster Pharmaceuticals, LLC × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 100 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 💊Topical cream, ointment or gel | ||||
| 50 mg/g | Topical | Alembic Pharmaceuticals Inc. | ANDA | View NDC → |
| 75 mg/g | Topical | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 50 mg/g | Topical | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 75 mg/g | Topical | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 50 mg/g | Topical | Allergan, Inc. × 2 listings | NDA | View NDC → |
| 75 mg/g | Topical | Allergan, Inc. | NDA | View NDC → |
| 50 mg/g | Topical | Almirall, Llc × 2 listings | NDA | View NDC → |
| 75 mg/g | Topical | Almirall, LLC × 3 listings | NDA | View NDC → |
| 50 mg/g | Topical | Amneal Pharmaceuticals LLC × 2 listings | ANDA | View NDC → |
| 50 mg/g | Topical | Aurobindo Pharma Limited | ANDA | View NDC → |
| 50 mg/g | Topical | Cosette Pharmaceuticals, Inc. | ANDA | View NDC → |
| 50 mg/g | Topical | Mayne Pharma | ANDA | View NDC → |
| 75 mg/g | Topical | Mayne Pharma Commercial LLC × 2 listings | ANDA | View NDC → |
| 75 mg/g | Topical | Mayne Pharma Inc. | ANDA | View NDC → |
| 75 mg/g | Topical | Mylan Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 50 mg/g | Topical | Northstar Rx Llc × 2 listings | ANDA | View NDC → |
| 75 mg/g | Topical | Northstar Rx Llc × 2 listings | ANDA | View NDC → |
| 50 mg/g | Topical | Pacific Pharma, Inc. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 50 mg/g | Topical | Pacific Pharma, Inc. | NDA | View NDC → |
| 50 mg/g | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 75 mg/g | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 50 mg/g | Topical | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 75 mg/g | Topical | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 75 mg/g | Topical | Torrent Pharmaceuticals Limited × 3 listings | ANDA | View NDC → |
| 75 mg/g | Topical | Trupharma, LLC | ANDA | View NDC → |
| 75 mg/g | Topical | Viona Pharmaceuticals Inc | ANDA | View NDC → |
| 75 mg/g | Topical | Zydus Lifesciences Limited | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 25 kg/25 kg | — | Atul Ltd | BULK INGREDIENT | View NDC → |
| 1 g/g | — | AX Pharmaceutical Corp | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Cohance Lifesciences Limited | BULK INGREDIENT | View NDC → |
| 100 g/100 g | — | Darmerica, Llc | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Dipharma Francis Srl × 2 listings | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Fagron Inc | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Haleos Labs Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Letco Medical, Llc | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Lundbeck Pharmaceuticals Italy S.p.A. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 1 kg/kg | — | Medilux Laboratories Private Limited | BULK INGREDIENT | View NDC → |
| 35 kg/35 kg | — | Nuray Chemicals Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America dba PCCA | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 25 kg/25 kg | — | Professional Compounding Centers of America dba PCCA | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 35 kg/35 kg | — | Professional Compounding Centers of America dba PCCA | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 25 kg/25 kg | — | Sai Life Sciences Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Spectrum Laboratory Products, Inc. | BULK INGREDIENT | View NDC → |
| 35 kg/35 kg | — | Sthree Chemicals Private Limited | BULK INGREDIENT | View NDC → |
Showing 113 of 113 products — FDA National Drug Code Directory. See every product, package size and price: browse all 113 Dapsone NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Dapsone — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Dapsone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Dapsone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 3108 2 dose forms · 5 strengths
-
Dose form (SCDF) Oral Tablet RxCUI 371689In current FDA listings -
Dose form (SCDF) Topical Gel RxCUI 607294In current FDA listings
Look up RxCUI 3108 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Dapsone is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Dapsone belongs to the Sulfone class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 19 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Westminster Pharmaceuticals, LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.